Vitamin D-mediated immune regulation in multiple sclerosis

Area of Science:

• Immunology
• Neuroscience
• Endocrinology

Background:

• Vitamin D is known for calcium regulation but also modulates the immune system.
• Observational studies suggest a protective role for Vitamin D in Multiple Sclerosis (MS), with lower MS risk linked to sun exposure and Vitamin D supplementation.
• Elevated Vitamin D levels correlate with a reduced risk of developing MS.

Purpose of the Study:

• To investigate the regulatory mechanisms of Vitamin D in the pathogenesis of Multiple Sclerosis (MS).
• To compare Vitamin D levels in different MS patient groups (relapsing-remitting and primary progressive) and healthy controls.
• To elucidate the effects of Vitamin D on T cell function and immune responses relevant to MS.

Main Methods:

• Studied 132 Hispanic MS patients (RRMS in remission/relapse, PPMS) and 60 healthy controls.
• Measured serum levels of 25(OH) Vitamin D and 1,25(OH)(2) Vitamin D using ELISA.
• Assessed the impact of 1,25(OH)(2) Vitamin D on T cell proliferation, cytokine production (IL-10, IL-6, IL-17), VDR expression, IDO activity, and T regulatory cell development.

Main Results:

• Significantly lower levels of 25(OH) Vitamin D and 1,25(OH)(2) Vitamin D were observed in RR MS patients compared to controls.
• Vitamin D levels were lower during MS relapses than during remission.
• 1,25(OH)(2) Vitamin D inhibited T cell proliferation, reduced pro-inflammatory cytokines (IL-6, IL-17), increased IL-10, enhanced IDO activity, and promoted T regulatory cell expansion. T cells were found to metabolize 25(OH) Vitamin D to 1,25(OH)(2) Vitamin D.

Conclusions:

• 1,25(OH)(2) Vitamin D plays a crucial role in maintaining T cell homeostasis in Multiple Sclerosis.
• Vitamin D deficiency is associated with MS, particularly during relapses.
• Correcting Vitamin D deficiency may be a beneficial therapeutic strategy for MS patients.